Concentra Group Holdings Parent (CON) Beats Again And Expands In Florida, Is The Stock Still Undervalued?
Concentra Group Holdings Parent (CON) reported another earnings beat in August 2026 and expanded its presence in Florida, leading to a significant 87.38% year-to-date share price return. Despite this rally, the stock is considered 9% undervalued with a fair value estimate of $39.88 against its current price of $36.37. The company's expansion and focus on workforce health compliance position it well for future growth, though high leverage and integration costs present potential risks.
Concentra Group Holdings Parent Inc stock hits all-time high at 35.94 USD
Concentra Group Holdings Parent Inc. stock has reached an all-time high of $35.94, representing a 67.78% increase over the past year and a 79% year-to-date return, driven by strong investor confidence. This milestone follows robust second-quarter financial results, including $606 million in revenue and $0.52 adjusted EPS, leading to an S&P Global Ratings upgrade to BB from BB-. Despite this success, InvestingPro analysis suggests the stock might be overvalued relative to its Fair Value estimate.
Concentra Group Holdings Parent Inc stock hits all-time high at 35.94 USD
Concentra Group Holdings Parent Inc. (CON) stock hit an all-time high of $35.94, trading just 1% below its 52-week high with a market capitalization of $4.46 billion. The stock has seen significant growth, with a 67.78% increase over the past year and a 79% year-to-date return, reflecting strong investor confidence despite being considered overvalued by InvestingPro analysis. This surge follows robust Q2 financial results, including $606 million in revenue and increased EPS, leading to an S&P Global Ratings upgrade.
A new clinic opens in Daytona Beach for workplace care
Concentra (CON) has opened its first occupational health medical center in Volusia County, Florida, located in Daytona Beach. This new facility aims to expand access to occupational health services for employers and employees in the greater Daytona region, offering services like work injury care, physical therapy, and drug screening. The opening is seen as a sign of continued growth for Daytona Beach and reflects Concentra's investment in Florida's increasing demand for workforce health solutions.
Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Concentra Group Holdings Parent, Inc. (CON)
This article highlights bullish sentiments from analysts on OS Therapies Incorporated (OSTX) and Concentra Group Holdings Parent, Inc. (CON). Roth MKM analyst Adam Walsh maintained a Buy rating on OSTX with a $7.00 price target, while William Blair's Jared Haase maintained a Buy rating on CON. Both companies have a Strong Buy consensus rating from analysts, with significant upside potential.
Concentra Group Holdings Appoints New CFO
Concentra Group Holdings has announced the appointment of Tanner Newton as Chief Financial Officer, effective November 1, as part of a multi-year leadership succession plan. Current CFO Matt DiCanio will transition to President and CEO on the same date. The market reacted positively, with Concentra's stock rising in pre-market trading, reflecting enhanced investor confidence in the company's financial management and future growth strategies.
Concentra Group Holdings Parent Updates Robert A. Ortenzio's Stake to 5.3% (NYSE: CON)
Concentra Group Holdings Parent (NYSE: CON) has updated Robert A. Ortenzio's beneficial ownership to 6,648,222 common shares, representing approximately 5.3% of outstanding shares. This correction rectifies an administrative error from a previous report which stated a 5.2% stake. Ortenzio has sole voting and disposition authority over a portion of these shares and shared authority over others, including those held in related trusts.
Concentra Group Holdings Parent, Inc. (CON) corrects a major holder’s stake after an earlier counting error
Concentra Group Holdings Parent, Inc. (CON) received an amended Schedule 13D from stockholder Robert A. Ortenzio, correcting an administrative error in his previously reported holdings. Ortenzio now beneficially owns 6,648,222 shares, or approximately 5.3% of the outstanding common stock. This amendment clarifies his sole and shared voting and dispositive powers over these shares, affecting 4,663,794 shares with sole power and 1,984,428 shares with shared power.
Director's 1M-share sale back to Concentra (CON) gets a filing fix
Concentra Group Holdings Parent, Inc. (CON) has filed an amended Form 4 to correct administrative errors and add an omitted indirect holding related to a previously reported 1M-share insider sale by director Robert A. Ortenzio and related trusts. The transactions, involving the repurchase of shares by the company at $34.65 per share, were approved by the Audit Committee for exemption under Rule 16b-3(e). The amendment clarifies the breakdown of direct and indirect holdings after the disposition, without introducing any new transactions.
S&P upgrades Concentra rating to BB on lower leverage By Investing.com
S&P Global Ratings has upgraded Concentra Group Holdings Parent Inc. (NYSE: CON) to BB from BB-, citing strong operating performance and significantly lower leverage. This upgrade follows Concentra's separation from Select Medical, with adjusted leverage falling below 3.5x in Q2, ahead of forecasts. The company's stable outlook reflects expectations of maintaining leverage below 3.5x, driven by robust free operating cash flow and a dominant market share in occupational health.
Concentra Group Holdings Completes $34.65M Share Buyback from Chairman Robert A. Ortenzio
Concentra Group Holdings Parent, Inc. completed a $34.65 million share buyback from its Board Chairman Robert A. Ortenzio and affiliated entities. The company repurchased 1,000,000 common stock shares at $34.65 per share, representing a 1% discount to the closing price on August 21, 2026. This privately negotiated transaction, approved by the Audit and Compliance Committee, was financed using the company's available cash and was part of an existing buyback program.
Concentra Group Holdings Parent, Inc. (CON) director sells 1M shares
Concentra Group Holdings Parent, Inc. (CON) purchased 1,000,000 shares of common stock at $34.65 per share from director Robert A. Ortenzio and associated family trusts. Ortenzio directly disposed of 770,000 shares and indirectly disposed of 230,000 shares through family trusts. Following the transaction, he directly holds 4,763,794 shares, with additional indirect holdings.
Should Concentra’s New CMO Shape a Deeper Clinical Edge in Workforce Health for (CON) Investors?
Concentra Group Holdings Parent, Inc. announced the appointment of Jill Rosenthal, MD, MPH, as its new chief medical officer, effective January 1, 2027, succeeding Dr. John Anderson. Dr. Rosenthal's experience in clinical leadership and occupational medicine is expected to support Concentra's clinical execution, though the immediate focus remains on debt management and EBITDA margins. This leadership change, alongside a new CEO succession plan, is anticipated to influence the company's clinic expansion and integrated workforce health offerings.
Concentra (CON) agrees to $34,650,000 buyback with Ortenzio family
Concentra Group Holdings Parent, Inc. (CON) has entered into a Stock Repurchase Agreement to buy back 1,000,000 shares of its common stock from Robert A. Ortenzio and related family trusts for a total of $34,650,000, at a price of $34.65 per share. Following this transaction, Ortenzio's beneficial ownership in Concentra will be 6,748,222 shares, representing approximately 5.3% of the outstanding shares. The agreement was made on August 21, 2026, and details the voting and dispositive powers over these shares.
CON | Concentra Group Holdings Parent, Insider Trading
This page provides an overview of Concentra Group Holdings Parent, Inc. (CON), focusing on insider trading activities, congressional stock trades, institutional holdings, and other financial data. It details recent transactions by U.S. Congress members and offers tools for analyzing stock performance and insider movements. The page also includes company information, executive compensation estimates, and links to various financial data points like income statements and analyst ratings.
Bank of America Corp DE Has $16.45 Million Stake in Concentra Group Holdings Parent, Inc. $CON
Bank of America Corp DE significantly reduced its stake in Concentra Group Holdings Parent, Inc. (NYSE:CON) by 39.7% in the first quarter, now holding 767,093 shares valued at $16.45 million. Despite this reduction, other institutional investors increased their holdings, and analysts have issued "Buy" or "Outperform" ratings with an average target price of $37.00 for the company. Concentra Group Holdings Parent also announced a quarterly dividend and reported strong financial results, beating earnings and revenue expectations.
Concentra Group (CON) is a Great Momentum Stock: Should You Buy?
Concentra Group (CON) is highlighted as a strong momentum stock, warranting investor attention. The article discusses Concentra's impressive price performance over various periods, outperforming both its industry and the S&P 500. Furthermore, positive earnings estimate revisions and a Zacks Rank of #2 (Buy) contribute to its favorable outlook.
Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health
Concentra announced the appointment of Dr. Jill Rosenthal as Chief Medical Officer, effective January 1, 2027. Dr. Rosenthal, a nationally recognized occupational medicine leader and current president of ACOEM, will lead Concentra's clinical strategy, innovation, and quality initiatives. She succeeds Dr. John Anderson and aims to strengthen Concentra's position as a leading occupational health provider.
How Investors Are Reacting To Concentra Group Holdings Parent (CON) Earnings Beat, Guidance Hike And CEO Transition
Concentra Group Holdings Parent (CON) reported strong Q2 2026 results, beating sales and net income expectations, and subsequently raised its full-year 2026 earnings guidance. The company also announced a planned CEO transition effective November 1, 2026, and declared a dividend, signaling operational momentum and governance continuity. This positive news supports Concentra's investment narrative, although some analysts remain cautious about long-term growth sustainability.
How Investors Are Reacting To Concentra Group Holdings Parent (CON) Earnings Beat, Guidance Hike And CEO Transition
Concentra Group Holdings Parent, Inc. (CON) reported strong second-quarter 2026 results, beating earnings expectations and raising its full-year guidance for both revenue and net income. The company also announced a planned CEO transition and continues its share repurchase program and dividend distribution. These developments reinforce Concentra's operational momentum and governance continuity, contributing to a positive investment narrative despite potential risks related to visit growth and reimbursement trends.
Concentra Group Holdings Parent Inc stock hits all-time high at 35.16 USD
Concentra Group Holdings Parent Inc. stock has reached an all-time high of $35.16, contributing to a market capitalization of $4.48 billion and marking a 79% year-to-date return. Despite its overvalued status according to InvestingPro, the company demonstrates strong financial health with a Piotroski Score of 9. This performance follows a robust second quarter, with revenue increasing by 10% to $606 million and adjusted EPS of $0.52, leading to raised full-year financial guidance.
Concentra Group Holdings Parent (NYSE:CON) Sets New 1-Year High - Here's Why
Concentra Group Holdings Parent (NYSE:CON) has reached a new 52-week high of $35.33, driven by positive analyst sentiment and strong financial performance. The company surpassed quarterly earnings expectations with an EPS of $0.52 and revenue of $606.03 million, marking a 10% year-over-year increase. Despite some insider selling, institutional investors have increased their stakes, and analysts maintain a "Moderate Buy" rating with a consensus target price of $37.00.
BofA Securities Adjusts Concentra Group Price Target to $40 From $36
BofA Securities has increased its price target for Concentra Group to $40 from the previous $36. The firm maintains a Neutral rating on the company's stock. This adjustment reflects a revised outlook on Concentra Group by BofA Securities.
BofA Securities Adjusts Price Target on Concentra Group to $40 From $36
BofA Securities has raised its price target for Concentra Group Holdings Parent, Inc. (CON) to $40 from $36, as reported by MT Newswires.
Analysts Offer Insights on NA Companies: Rapid7 (RPD) and Concentra Group Holdings Parent, Inc. (CON)
Analysts from BTIG and Wells Fargo have provided insights on Rapid7 (RPD) and Concentra Group Holdings Parent, Inc. (CON). BTIG maintained a Hold rating for Rapid7, while Wells Fargo assigned a Buy rating to Concentra, indicating potential upside. This report summarizes recent analyst actions and price targets for both companies.
Concentra Group Holdings Parent, Inc. Just Recorded A 25% EPS Beat: Here's What Analysts Are Forecasting Next
Concentra Group Holdings Parent, Inc. (NYSE:CON) recently reported its Q2 results, surpassing revenue and EPS estimates. Analysts have updated their forecasts, showing increased optimism for the company's earnings potential, leading to a 6.0% rise in the consensus price target. While revenue growth is expected to slow compared to historical rates, it is projected to remain in line with industry growth estimates.
Concentra Group Holdings Parent, Inc. Stock 12‑Month Price Target Raised to $39.12, Implies 18% Upside
The average 12-month price target for Concentra Group Holdings Parent, Inc. stock has been raised from $38.62 to $39.12 by 8 analysts, with a range of $34 to $42. This new target implies an 18% potential upside based on the Aug. 11 closing price. The consensus rating from 9 covering analysts remains "Buy," with no "Holds" or "Sells."
Concentra Group Holdings Parent (CON) Is Up 7.6% After Raising 2026 Guidance And Detailing CEO Succession – Has The Bull Case Changed?
Concentra Group Holdings Parent (CON) recently announced strong Q2 2026 results, raising full-year 2026 guidance and reaffirming its quarterly dividend. The company also detailed a CEO succession plan, with Matt DiCanio set to take over in November 2026, while current CEO Keith Newton will become executive chairman. These developments are viewed positively, reinforcing the company's growth story and capital return program, though high leverage remains a key consideration for investors.
Concentra Group Holdings Parent (CON) Is Up 7.6% After Raising 2026 Guidance And Detailing CEO Succession – Has The Bull Case Changed?
Concentra Group Holdings Parent (CON) recently reported strong Q2 2026 results, raising full-year guidance and reaffirming its dividend. The company also announced a CEO succession plan, with current President and CFO Matt DiCanio set to take over in November 2026. This positive news, coupled with continued stock buybacks, has led to a 7.6% stock increase, though investors should consider the company's high leverage and valuation relative to consensus targets.
Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?
Concentra Group Holdings Parent, Inc. (CON) recently hit a 52-week high of $35.15, with shares up 8% over the past month and 73.1% year-to-date. This outperformance is driven by a strong record of positive earnings surprises, with the company beating consensus estimates in the last four quarters. Despite trading at a premium compared to its peers, Concentra holds a Zacks Rank of #2 (Buy) and strong Style Scores for Growth and Momentum, suggesting potential for continued growth.
Concentra Group Holdings Parent, Inc. Just Recorded A 25% EPS Beat: Here's What Analysts Are Forecasting Next
Concentra Group Holdings Parent, Inc. (NYSE:CON) reported strong second-quarter results, exceeding revenue and EPS expectations. Analysts have increased their earnings per share estimates and raised the consensus price target to US$35.38, indicating increased optimism. Despite a projected slowdown in revenue growth, it is expected to align with the industry average.
CONCENTRA GROUP HOLDINGS PARENT INC : RBC RAISES TARGET PRICE TO $42 FROM $36
RBC has increased its target price for CONCENTRA GROUP HOLDINGS PARENT INC (CON.N) to $42 from the previous $36. This updated target reflects an optimistic outlook from RBC regarding the company's future performance.
Concentra Group Holdings Parent (CON) Is Up 7.6% After Raising 2026 Outlook And Announcing CEO Transition
Concentra Group Holdings Parent (CON) saw its stock rise 7.6% after reporting Q2 2026 results, raising its full-year 2026 outlook, affirming a dividend, and announcing a CEO transition effective November 1, 2026. The company now expects revenues between US$2.325 billion and US$2.375 billion and net income between US$210 million and US$217 million. Despite the positive outlook, the article highlights the continued risk of elevated leverage for the company.
Sei Investments Co. Boosts Stake in Concentra Group Holdings Parent, Inc. $CON
Sei Investments Co. significantly increased its stake in Concentra Group Holdings Parent, Inc. by 51.4% in the first quarter, now owning 172,210 shares valued at approximately $3.7 million. Other institutional investors also raised their positions, reflecting positive sentiment. Concentra reported strong quarterly earnings of $0.52 per share, beating estimates, with revenue up 10% year-over-year, while analysts maintain a "Moderate Buy" rating despite recent insider share sales.
Concentra Group Holdings Parent, Inc. Stock 12‑Month Price Target Raised to $34.62, Implies 13% Upside
The average 12-month price target for Concentra Group Holdings Parent, Inc. (CON) stock has been raised to $34.62, up from $33.38, according to estimates from 8 analysts. This updated target implies a 13% potential upside based on the Aug. 6 closing price, with forecasts ranging from $28 to $40 per share. The consensus rating among 9 covering analysts remains "Buy," with no Hold or Sell recommendations.
Concentra Group Holdings Parent (NYSE:CON) Reaches New 12-Month High After Earnings Beat
Concentra Group Holdings Parent (NYSE:CON) hit a new 52-week high after reporting better-than-expected quarterly earnings, with EPS of $0.52 against a $0.42 consensus and revenue of $606.03 million, up 10% year-over-year. Analysts remain largely positive, with seven rating the stock a "Buy" and one a "Hold," and Truist raising its price target to $37. The company also declared a quarterly dividend of $0.0625 per share, though insiders have sold a significant number of shares recently.
Earnings call transcript: Concentra Q2 2026 profit, guidance raise lift shares 11%
Concentra Group Holdings Parent Inc. reported strong Q2 2026 results with a 10% increase in revenue to $606 million and adjusted EPS of $0.52, leading to an 11% surge in shares. The company also raised its full-year 2026 guidance for revenue, adjusted EBITDA, and free cash flow, attributing the success to higher visit volume, stronger pricing, market share gains, and technology upgrades. CEO Keith Newton announced his transition to Executive Chairman, with President and CFO Matt DiCanio set to take over as CEO, assuring continuity in strategy.
Earnings Flash (CON) Concentra Group Holdings Parent, Inc. Posts Q2 Adjusted EPS $0.52 per Share, Vs. FactSet Est of $0.42
Concentra Group Holdings Parent, Inc. (CON) announced its Q2 adjusted EPS of $0.52 per share, exceeding the FactSet estimate of $0.42 per share. This indicates a stronger financial performance than anticipated by analysts for the quarter.
Concentra Group Holdings Parent, Inc. (CON) Stock Price, News, Quote & History
This Yahoo Finance page provides comprehensive information on Concentra Group Holdings Parent, Inc. (CON) stock, including its current price, historical data, financial overview, and analyst insights. The stock closed at $34.06 on August 7, 2026, up 11.53%, with significant year-to-date and one-year returns. The company, which offers occupational health services, reported Q1 FY26 revenue of $569.55M and earnings of $50.49M.
CON: Q2 2026 delivered robust revenue and EBITDA growth, with raised full-year guidance and lower leverage
Concentra Group Holdings (CON) reported strong Q2 2026 results, showing double-digit revenue and Adjusted EBITDA growth, along with margin expansion and increased volumes in core services. The company also raised its full-year guidance for revenue, EBITDA, and free cash flow, achieving its leverage targets earlier than expected.
Concentra Q2 2026 earnings: Operating leverage lifts profit and cash flow
Concentra (NYSE: CON) reported a strong Q2 2026, with revenue up 10.0% to $606.0 million and diluted EPS rising to $0.51 from $0.35. The company benefited from operating leverage, as costs grew slower than revenue, leading to a 46.5% increase in net income and a significant boost in free cash flow by 91.6%. Concentra also raised its full-year 2026 guidance and announced a planned leadership transition.
Earnings Flash (CON) Concentra Group Holdings Parent, Inc. Posts Q2 Adjusted EPS $0.52 per Share, vs. FactSet Est of $0.42
Concentra Group Holdings Parent, Inc. reported Q2 adjusted EPS of $0.52 per share, surpassing the FactSet estimate of $0.42. The company also announced an increase in its 2026 revenue guidance, board changes, and the appointment of Matt DiCanio as CEO.
Concentra Group Holdings Parent Inc (CON) Q2 2026 Earnings Report Preview: What To Expect
Concentra Group Holdings Parent Inc (CON) is scheduled to release its Q2
Concentra Group Holdings Parent, Inc. (NYSE: CON) director sells 130,000 shares
Concentra Group Holdings Parent, Inc. (NYSE: CON) director Robert A. Ortenzio sold 130,000 shares of common stock on August 3, 2026, at a weighted average price of $31.8412 per share. The sale, valued at $4.14 million, was executed indirectly through The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio as part of a pre-arranged trading plan. Post-transaction, Ortenzio maintains significant direct and indirect holdings in the company.
Concentra Group Holdings Parent, Inc. 2026: Revenue $606.03M, EPS $0.51— 10-Q Summary
Concentra Group Holdings Parent, Inc. reported strong financial results for the 2026 quarter, with revenue reaching $606.03 million and diluted earnings per share at $0.51. This represents a 10% year-over-year revenue growth and a 45.7% increase in diluted EPS, driven by higher patient visits, a shift towards onsite clinics, and improved operational efficiency. The company expanded its network to 633 centers and 415 onsite clinics and reduced its cost of services.
Concentra Group Holdings Parent, Inc. (NYSE:CON) Given Average Rating of "Moderate Buy" by Brokerages
Concentra Group Holdings Parent, Inc. (NYSE:CON) has received an average "Moderate Buy" rating from eight brokerages, with an average 12-month price target of $31.40. The company recently exceeded earnings expectations, reporting EPS of $0.40 against an estimated $0.35, and revenue of $569.55 million, a 13.7% year-over-year increase. Despite strong stock performance and a share price near its 52-week high, insider selling has been observed, with Director Robert A. Ortenzio selling 130,000 shares for approximately $4.0 million.
Concentra Group Holdings Parent (CON) Stock Analysis: Robust Growth and Strong Buy Ratings Fuel Investor Optimism
Concentra Group Holdings Parent (CON) is showing strong growth in the healthcare sector, with a robust revenue increase of 13.70% and an impressive return on equity of 47.00%. The company's stock, currently at $31.70, has a positive outlook from analysts, with nine buy ratings and an average price target suggesting a 5.28% upside. Despite some technical indicators suggesting the stock is overbought in the short term, its strong financial fundamentals and strategic positioning in occupational health make it an attractive investment.
CONMED (CON) trusts detail 130,000-share planned sale and recent large stock trades
CONMED Corporation's affiliated trusts have filed a Form 144 for the potential sale of 130,000 common shares through UBS Financial Services Inc., with an aggregate market value of $4,114,500. This planned sale represents a small fraction of the 127,961,780 shares outstanding as of August 3, 2026. The filing also details several large past sales by The Rocco A Ortenzio Trust FBO Robert Ortenzio and The Revocable Trust of Rocco A Ortenzio, including blocks up to 259,940 shares.
Form 144 Concentra Group Holdings Parent For: 3 August By Investing.com
This article announces a Form 144 filing by Concentra Group Holdings Parent for August 3rd. It is a brief, one-line report from Investing.com, providing no additional details or context about the filing. The article also includes a stock market snapshot with various indices and commodity prices.
Concentra Group Holdings Parent Inc (CON) Financial Health: Profitability & Balance Sheet Analysis
Concentra Group Holdings Parent Inc (CON) has a current financial score of 8.02, ranking 28 out of 75 in the Healthcare Providers & Services industry, indicating a weak financial status but high operating efficiency. The company's latest quarterly revenue was $569.55 million, a 13.74% year-over-year increase, with net profit rising 28.52% year-over-year. While some data on financial aspects like cash and assets are pending disclosure, the company shows strong growth potential and shareholder returns.
